ABEO logo

ABEO
Abeona Therapeutics Inc

10,991
Mkt Cap
$312.9M
Volume
13.00
52W High
$7.54
52W Low
$4.00
PE Ratio
5.73
ABEO Fundamentals
Price
$5.37
Prev Close
$5.49
Open
$5.49
50D MA
$5.13
Beta
0.72
Avg. Volume
976,586.51
EPS (Annual)
$1.01
P/B
2.11
Rev/Employee
$25,752.21
$182.10
Loading...
Loading...
News
all
press releases
Abeona Therapeutics Q1 2026 Earnings Call: Complete Transcript
read more...
Benzinga·6d ago
News Placeholder
More News
News Placeholder
Abeona Reports Strong Q1 Revenue, Expands Treatment Center Network
Abeona Therapeutics Inc. (NASDAQ: ABEO) reported first-quarter earnings Wednesday before the market opened. Here's a rundown of the report.read more...
Benzinga·6d ago
News Placeholder
Abeona Therapeutics (ABEO) to Release Quarterly Earnings on Wednesday
Abeona Therapeutics (NASDAQ:ABEO) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-abeona-therapeutics-inc-stock...
MarketBeat·13d ago
News Placeholder
Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the c...
MarketBeat·15d ago
News Placeholder
2,000,000 Shares in Abeona Therapeutics Inc. $ABEO Purchased by AIGH Capital Management LLC
AIGH Capital Management LLC purchased a new position in Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,000,000 shares of the biopharmaceutical compa...
MarketBeat·17d ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50 Day Moving Average - Here's What Happened
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Crosses Above Fifty Day Moving Average - What's Next...
MarketBeat·21d ago
News Placeholder
Aberdeen Group plc Makes New $3.25 Million Investment in Abeona Therapeutics Inc. $ABEO
Aberdeen Group plc acquired a new position in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Issues Pessimistic Outlook for ABEO Earnings
Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright decreased their Q1 2026 EPS estimates for Abeona Therapeutics in a report released on Thursday, March 19th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post ear...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Abeona Therapeutics in a research report on Thursday...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics Q4 Earnings Call Highlights
Abeona Therapeutics (NASDAQ:ABEO) executives said the company is seeing growing patient demand for ZEVASKYN, an autologous cell-based gene therapy approved in April 2025 for adults and pediatric...
MarketBeat·2mo ago
<
1
2
...
>

Latest ABEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.